<DOC>
	<DOCNO>NCT02411357</DOCNO>
	<brief_summary>Nearly 9 every 10 pregnant opioid-dependent woman report current pregnancy unintended majority non-pregnant opioid-maintained woman use contraception use less effective method like condom . This proposal aim test novel contraceptive management program increase use effective contraceptive among opioid-maintained woman risk unintended pregnancy .</brief_summary>
	<brief_title>Improving Effective Contraceptive Use Among Opioid-maintained Women : Stage II</brief_title>
	<detailed_description>The rate unintended pregnancy among opioid-dependent woman extremely high : nearly 9 every 10 pregnant opioid-dependent woman report current pregnancy unintended , rate 2-3 time general population . Despite dire statistic , dearth scientific knowledge contraceptive use population promote use effective contraceptive ( e.g. , birth control pill , IUDs , implant ) . The aim Stage II Behavioral Integrative Treatment Development Program application test novel contraceptive management program increase use effective contraceptive among OM woman . OM woman risk unintended pregnancy ( N=195 ) randomly assign one three condition : ( 1 ) usual care , ( 2 ) World Health Organization ( WHO ) contraception protocol , ( 3 ) WHO contraception protocol + financial incentive . Participants usual care condition receive referral local contraceptive provider . Participants WHO alone condition receive WHO contraceptive initiation protocol choice prescription contraceptive consultation nurse practitioner . These participant also subsequently offer opportunity attend 13 follow-up visit vital sign urine pregnancy test administer . Side effect prescription contraception also assess participant option change prescription contraceptive method time . Participants WHO + incentive condition also receive WHO contraceptive initiation protocol choice prescription contraceptive consultation nurse practitioner . These participant also subsequently offer opportunity attend 13 follow-up visit vital sign urine pregnancy test administer . Side effect prescription contraception assess participant option change prescription contraceptive method time . Participants WHO + incentive condition participant also earn voucher exchangeable good service attend visit . Contraceptive use participant evaluate assessment schedule 1 , 3 , 6 , 12 month trial intake .</detailed_description>
	<mesh_term>Contraceptive Agents</mesh_term>
	<criteria>1844 year age premenopausal history tubal ligation hysterectomy heterosexual vaginal sex past 3 month plan become pregnant next 6 month medically eligible use prescription contraceptive report prescription contraceptive use ( i.e. , use pill , patch , ring , implant , IUDs past 7 day injection past 3 month ) opioid maintenance treatment face imminent incarceration plan leave area next 12 month Englishspeaking failure meet aforementioned inclusion criterion refusal participate</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>44 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Contraception</keyword>
	<keyword>Unintended pregnancy</keyword>
	<keyword>HIV risk</keyword>
	<keyword>Sexually transmit infection</keyword>
	<keyword>Women</keyword>
	<keyword>Pregnancy</keyword>
	<keyword>Neonatal health</keyword>
	<keyword>Drug use</keyword>
	<keyword>Drug treatment</keyword>
	<keyword>Opioids</keyword>
</DOC>